Published in Bioconjug Chem on March 16, 2005
Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery. Biomaterials (2009) 1.29
Synthesis and characterization of nanoscale dendritic RGD clusters for potential applications in tissue engineering and drug delivery. Int J Nanomedicine (2007) 0.93
Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells. Int J Pharm (2009) 0.91
Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo. Anticancer Drugs (2010) 0.91
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials. Br J Pharmacol (2014) 0.90
Electrophoretic Behavior of Anionic Triazine and PAMAM Dendrimers: Methods for Improving Resolution and Assessing Purity Using Capillary Electrophoresis. Macromolecules (2009) 0.87
Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications. Biomacromolecules (2010) 0.86
Influence of dendrimer surface charge on the bioactivity of 2-methoxyestradiol complexed with dendrimers. Soft Matter (2010) 0.85
Effects of branching architecture and linker on the activity of hyperbranched polymer-drug conjugates. Bioconjug Chem (2009) 0.83
Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier. Mol Pharm (2013) 0.82
Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting. Bioconjug Chem (2008) 0.82
Uptake, efflux, and mass transfer coefficient of fluorescent PAMAM dendrimers into pancreatic cancer cells. Biochim Biophys Acta (2012) 0.78
Bioconjugates of PAMAM dendrimers with trans-retinal, pyridoxal, and pyridoxal phosphate. Int J Nanomedicine (2012) 0.78
Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight? Int J Clin Rheumtol (2011) 0.75
Nanomedicine approaches for corneal diseases. J Funct Biomater (2015) 0.75
Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases. Adv Healthc Mater (2015) 0.75
Effect of methotrexate conjugated PAMAM dendrimers on the viability of MES-SA uterine cancer cells. J Pharm Bioallied Sci (2014) 0.75
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med (2012) 3.43
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today (2010) 2.03
Scholarly activity in the next accreditation system: moving from structure and process to outcomes. J Grad Med Educ (2013) 1.81
The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials (2008) 1.74
Intrauterine endotoxin administration leads to white matter diffusivity changes in newborn rabbits. J Child Neurol (2009) 1.58
A Practical Guide to the ACGME Self-Study. J Grad Med Educ (2014) 1.51
Relative deficiency of arginine vasopressin in children after cardiopulmonary bypass. Crit Care Med (2010) 1.49
Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm (2003) 1.36
Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy. Am J Obstet Gynecol (2008) 1.36
Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery. Biomaterials (2009) 1.29
Models of fetal brain injury, intrauterine inflammation, and preterm birth. Am J Reprod Immunol (2012) 1.26
Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines. Bioconjug Chem (2006) 1.19
Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels. Bioconjug Chem (2008) 1.13
Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload. Biomaterials (2005) 1.11
Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration. Biomaterials (2011) 1.10
Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Nanomedicine (2013) 1.09
Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration. Nanomedicine (Lond) (2010) 1.04
Nanotechnology approaches for ocular drug delivery. Middle East Afr J Ophthalmol (2013) 1.00
Incidence and costs of adverse drug reactions in a tertiary care pediatric intensive care unit. J Clin Pharmacol (2013) 1.00
Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers. Int J Pharm (2010) 1.00
Dendrimer-enabled modulation of gene expression in Chlamydia trachomatis. Mol Pharm (2012) 0.99
Predictors of red cell transfusion in children and adolescents undergoing spinal fusion surgery. Spine (Phila Pa 1976) (2002) 0.99
Drug release characteristics of PAMAM dendrimer-drug conjugates with different linkers. Int J Pharm (2009) 0.98
Solid-state characterization of rifampicin samples and its biopharmaceutic relevance. Eur J Pharm Sci (2004) 0.98
Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial carcinoma cells. J Biomater Sci Polym Ed (2004) 0.96
Injectable PAMAM dendrimer-PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation. Mol Pharm (2011) 0.96
Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest. ACS Nano (2014) 0.96
Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation. Mol Pharm (2013) 0.94
Transport and biodistribution of dendrimers across human fetal membranes: implications for intravaginal administration of dendrimer-drug conjugates. Biomaterials (2010) 0.93
An algorithm to detect adverse drug reactions in the neonatal intensive care unit. J Clin Pharmacol (2013) 0.92
Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells. Int J Pharm (2009) 0.91
Transfer of PAMAM dendrimers across human placenta: prospects of its use as drug carrier during pregnancy. J Control Release (2010) 0.91
Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers. Angew Chem Int Ed Engl (2013) 0.90
Dendrimer nanoparticles for ocular drug delivery. J Ocul Pharmacol Ther (2013) 0.89
Development of biotechnology products in pre-filled syringes: technical considerations and approaches. AAPS PharmSciTech (2011) 0.88
Kearns-Sayre syndrome presenting as complete heart block. Pediatr Cardiol (2007) 0.87
Improvement in ductility of chitosan through blending and copolymerization with PEG: FTIR investigation of molecular interactions. Biomacromolecules (2003) 0.87
Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications. Biomacromolecules (2010) 0.86
Comparison of traditional and plethysmographic methods for measuring pulsus paradoxus. Arch Pediatr Adolesc Med (2004) 0.86
Comparative evaluation of disodium edetate and diethylenetriaminepentaacetic acid as iron chelators to prevent metal-catalyzed destabilization of a therapeutic monoclonal antibody. J Pharm Sci (2010) 0.85
Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research. Curr Drug Metab (2004) 0.84
Effects of branching architecture and linker on the activity of hyperbranched polymer-drug conjugates. Bioconjug Chem (2009) 0.83
Poly(amidoamine) dendrimer-erythromycin conjugates for drug delivery to macrophages involved in periprosthetic inflammation. Nanomedicine (2010) 0.83
Hyperbranched polymer-drug conjugates with high drug payload for enhanced cellular delivery. Pharm Res (2004) 0.83
Reversal of methylprednisolone effects in allergen-exposed female BALB/c mice. J Toxicol Environ Health A (2010) 0.82
Frozen state storage instability of a monoclonal antibody: aggregation as a consequence of trehalose crystallization and protein unfolding. Pharm Res (2011) 0.82
Synthesis, characterization, and in vitro activity of dendrimer-streptokinase conjugates. Bioconjug Chem (2007) 0.82
Characterization of azithromycin hydrates. Eur J Pharm Sci (2002) 0.80
Maternal endotoxin exposure results in abnormal neuronal architecture in the newborn rabbit. Dev Neurosci (2013) 0.80
Augmented annotation and orthologue analysis for Oryctolagus cuniculus: Better Bunny. BMC Bioinformatics (2012) 0.80
Infants with single ventricle physiology in the emergency department: are physicians prepared? J Pediatr (2011) 0.80
Supercritical carbon dioxide processed resorbable polymer nanocomposite bone graft substitutes. Acta Biomater (2011) 0.80
Nanomedicine in cerebral palsy. Int J Nanomedicine (2013) 0.80
Enhancing the efficacy of Ara-C through conjugation with PAMAM dendrimer and linear PEG: a comparative study. Biomacromolecules (2013) 0.79
Solid-state characterization of mefenamic acid. J Pharm Sci (2004) 0.79
Hydroxyl PAMAM dendrimer-based gene vectors for transgene delivery to human retinal pigment epithelial cells. Nanoscale (2015) 0.78
PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections. Nanomedicine (2011) 0.78
Engineering strength, porosity, and emission intensity of nanostructured CdSe networks by altering the building-block shape. J Am Chem Soc (2008) 0.77
Concurrent quantification of tryptophan and its major metabolites. Anal Biochem (2013) 0.77
Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammation. J Control Release (2009) 0.77
Ibuprofen and increased morbidity in children with asthma: fact or fiction? Paediatr Drugs (2004) 0.77
A dendrimer-based immunosensor for improved capture and detection of tumor necrosis factor-α cytokine. Anal Chim Acta (2012) 0.76
Low thiamine levels in children with type 1 diabetes and diabetic ketoacidosis: a pilot study. Pediatr Crit Care Med (2015) 0.76
"Hot spots" in the brain: tissue to be rescued? Crit Care Med (2012) 0.75
752: MICROGLIAL PROLIFERATION IN THE PIGLET BRAIN IS REGION SPECIFIC AFTER CARDIAC ARREST. Crit Care Med (2016) 0.75
Immunomodulation in Critical Illness: The Quest Continues. Pediatr Crit Care Med (2017) 0.75
Activated microglia targeting dendrimer-minocycline conjugate as therapeutics for neuroinflammation. Bioconjug Chem (2017) 0.75